UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
[Special] ‘Healthcare policies fail to support long-term fight against Covid-19’
Five months have passed since the nation started a war against the new coro...
by Song Soo-youn/Kim Eun-young
|
2020-06-04 15:55
라인
‘Blood test can detect Alzheimer’s early’
Local researchers said they have clinically proven how to diagnose Alzheime...
by Park Gi-taek
|
2020-06-04 15:40
라인
Greater Seoul remains jittery over sporadic, silent spreads
Korea’s new Covid-19 cases have remained between 30 and 40 over the past fe...
by Shim Hyun-tai
|
2020-06-04 14:38
라인
MedPacto to test Vactosertib for treating NSCLC
MedPacto has applied for phase 2 clinical trials concerning the combined us...
by Lee Han-soo
|
2020-06-04 12:43
라인
Korea to spend ₩1 trillion on fight against infectious diseases
The Ministry of Health and Welfare said Wednesday that 1.05 trillion won ($...
by Shim Hyun-tai
|
2020-06-03 18:18
라인
Dupixent to provide new treatment options for asthma patients
Sanofi-Aventis Korea said Wednesday it would enter the local asthma drug ma...
by Lee Han-soo
|
2020-06-03 17:54
라인
[ASCO 2020 ④] MedPacto's Vactosertib combo treatment for desmoid tumors proved safe
MedPacto said the combination of its small molecule TGF-B inhibitor, Vactos...
by Shim Hyun-tai
|
2020-06-03 17:20
라인
New plasma-based method found to treat refractory blood cancer
A new method has been found to treat chronic myelogenous leukemia, a type o...
by Lee Han-soo
|
2020-06-03 16:29
라인
Seoul OKs special import of remdesivir as Covid-19 treatment
The Ministry of Food and Drug Safety said it has granted emergency approval...
by Kim Yun-mi
|
2020-06-03 16:05
라인
Treating helicobacter bacteria after gastric cancer surgery lifts survival rate
A research team at Seoul National University Bundang Hospital has discovere...
by Lee Han-soo
|
2020-06-03 16:05
라인
Korea confirms Covid-19 candidate drug’s effect through weasels
A locally developed antibody treatment candidate to fight Covid-19 showed a...
by Kwak Sung-sun
|
2020-06-03 16:05
라인
‘KOEDC to broaden drug accessibility for patients with rare diseases’
“As the head of Korea Orphan and Essential Drug Center putting patients fir...
by Kim Yun-mi
|
2020-06-03 12:37
라인
Unrelenting church-linked infections raise worries about new viral wave
Korea’s new Covid-19 cases rebounded on Wednesday, as cluster infections li...
by Shim Hyun-tai
|
2020-06-03 12:34
라인
‘Mental, behavioral disorders’ social costs larger than their medical expense’
Indirect social and economic costs caused by psychological and behavioral d...
by Shim Hyun-tai
|
2020-06-02 18:28
라인
[ASCO 2020 ③] Genexine’s combo therapy for breast cancer proves safety
Genexine said that the combination therapy of its Hyleukin-7 and MSD’s Keyt...
by Shim Hyun-tai
|
2020-06-02 17:14
라인
CDK 4/6 inhibitor market to heat up on insurance benefits
Hormone receptor (HR) positive, human epidermal growth factor receptor 2 (H...
by Lee Han-soo
|
2020-06-02 17:13
라인
‘54% of MERS survivors had mental illness even 1 year after recovery’
More than half of the survivors of the Middle East Respiratory Syndrome in ...
by Choi Gwang-seok
|
2020-06-02 15:38
라인
‘Covid-19 heroes? Nurses worry about pay cuts’
“Why should doctors and nurses fighting Covid-19 worry about money, too?”Sh...
by Song Soo-youn
|
2020-06-02 15:33
라인
Resurge of church-linked virus cases dims outlook for broader school reopening
Infections originating from smaller churches in the Seoul metro region are ...
by Shim Hyun-tai
|
2020-06-02 14:45
라인
‘Keytruda doubled survival in advanced colon cancer compared to chemo’
MSD’s Keytruda (ingredient: pembrolizumab) extended the progression-free su...
by Kim Yun-mi
|
2020-06-02 11:27
-
이전
21
22
23
24
25
26
27
28
29
30
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top